186 related articles for article (PubMed ID: 31183390)
1. Assessment of Salivary Levels of RANKL and OPG in Aggressive versus Chronic Periodontitis.
Teodorescu AC; Martu I; Teslaru S; Kappenberg-Nitescu DC; Goriuc A; Luchian I; Martu MA; Solomon SM; Mârțu S
J Immunol Res; 2019; 2019():6195258. PubMed ID: 31183390
[TBL] [Abstract][Full Text] [Related]
2. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio.
Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Atilla G; Hughes FJ; Belibasakis GN
J Clin Periodontol; 2007 May; 34(5):370-6. PubMed ID: 17355365
[TBL] [Abstract][Full Text] [Related]
3. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
Lu HK; Chen YL; Chang HC; Li CL; Kuo MY
J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
[TBL] [Abstract][Full Text] [Related]
4. RANKL upregulation associated with periodontitis and Porphyromonas gingivalis.
Wara-aswapati N; Surarit R; Chayasadom A; Boch JA; Pitiphat W
J Periodontol; 2007 Jun; 78(6):1062-9. PubMed ID: 17539720
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis.
Giannopoulou C; Martinelli-Klay CP; Lombardi T
Acta Odontol Scand; 2012 Dec; 70(6):629-34. PubMed ID: 22214279
[TBL] [Abstract][Full Text] [Related]
6. Saliva concentrations of RANKL and osteoprotegerin in smoker versus non-smoker chronic periodontitis patients.
Buduneli N; Biyikoğlu B; Sherrabeh S; Lappin DF
J Clin Periodontol; 2008 Oct; 35(10):846-52. PubMed ID: 18727653
[TBL] [Abstract][Full Text] [Related]
7. Emerging roles of Interleukin-34 together with receptor activator of nuclear factor-kB ligand and osteoprotegerin levels in periodontal disease.
Bozkurt Doğan Ş; Öngöz Dede F; Ballı U; Sertoğlu E
Cytokine; 2021 Aug; 144():155584. PubMed ID: 34034144
[TBL] [Abstract][Full Text] [Related]
8. Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.
Armada L; Marotta Pdos S; Pires FR; Siqueira JF
J Endod; 2015 Aug; 41(8):1281-7. PubMed ID: 25956608
[TBL] [Abstract][Full Text] [Related]
9. RANKL and OPG mRNA level after non-surgical periodontal treatment.
Dereka XE; Markopoulou CE; Fanourakis G; Tseleni-Balafouta S; Vrotsos IA
Inflammation; 2010 Jun; 33(3):200-6. PubMed ID: 20033478
[TBL] [Abstract][Full Text] [Related]
10. Receptor activator of nuclear factor kappa B ligand and osteoprotegerin expression in chronic apical periodontitis: possible association with inflammatory cells.
Fan R; Sun B; Zhang CF; Lü YL; Xuan W; Wang QQ; Yin XZ
Chin Med J (Engl); 2011 Jul; 124(14):2162-6. PubMed ID: 21933620
[TBL] [Abstract][Full Text] [Related]
11. The RANKL-OPG system in clinical periodontology.
Belibasakis GN; Bostanci N
J Clin Periodontol; 2012 Mar; 39(3):239-48. PubMed ID: 22092994
[TBL] [Abstract][Full Text] [Related]
12. Immune-Inflammatory Cell Profile and Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin Expression in Persistent Apical Periodontitis after Root Canal Retreatment Failure.
Estrela C; Decurcio Dde A; Silva JA; Batista AC; de Souza Lima NC; de Freitas Silva BS; de Souza JA; Souza Costa CA
J Endod; 2016 Mar; 42(3):439-46. PubMed ID: 26806398
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases.
Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Berdeli A; Atilla G; McKay IJ; Hughes FJ; Belibasakis GN
J Periodontal Res; 2007 Aug; 42(4):287-93. PubMed ID: 17559623
[TBL] [Abstract][Full Text] [Related]
14. The relationship between T-helper cell polarization and the RANKL/OPG ratio in gingival tissues from chronic periodontitis patients.
Bi CS; Sun LJ; Qu HL; Chen F; Tian BM; Chen FM
Clin Exp Dent Res; 2019 Aug; 5(4):377-388. PubMed ID: 31944625
[TBL] [Abstract][Full Text] [Related]
15. [Expression of receptor activator of nuclear factor kappaB ligand and osteoprotegerin in chronic apical periodontitis].
Fan R; Zhang CF; Gao Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 40(1):39-42. PubMed ID: 18278135
[TBL] [Abstract][Full Text] [Related]
16. Assessment of local and systemic 25-hydroxy-vitamin D, RANKL, OPG, and TNF levels in patients with rheumatoid arthritis and periodontitis.
Balci Yuce H; Gokturk O; Aydemir Turkal H; Inanir A; Benli I; Demir O
J Oral Sci; 2017; 59(3):397-404. PubMed ID: 28904316
[TBL] [Abstract][Full Text] [Related]
17. Production of Soluble Receptor Activator of Nuclear Factor Kappa-Β Ligand and Osteoprotegerin by Apical Periodontitis Cells in Culture and Their Modulation by Cytokines.
Duka M; Eraković M; Dolićanin Z; Stefanović D; Čolić M
Mediators Inflamm; 2019; 2019():8325380. PubMed ID: 31011287
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis.
Mogi M; Otogoto J; Ota N; Togari A
J Dent Res; 2004 Feb; 83(2):166-9. PubMed ID: 14742657
[TBL] [Abstract][Full Text] [Related]
19. Effects of Enterococcus faecalis lipoteichoic acid on receptor activator of nuclear factor-κB ligand and osteoprotegerin expression in periodontal ligament fibroblasts.
Zhao L; Chen J; Cheng L; Wang X; Du J; Wang F; Peng Z
Int Endod J; 2014 Feb; 47(2):163-72. PubMed ID: 23710898
[TBL] [Abstract][Full Text] [Related]
20. Transglutaminase 2 up-regulation is associated with RANKL/OPG pathway in cultured HPDL cells and THP-1-differentiated macrophages.
Matarese G; Currò M; Isola G; Caccamo D; Vecchio M; Giunta ML; Ramaglia L; Cordasco G; Williams RC; Ientile R
Amino Acids; 2015 Nov; 47(11):2447-55. PubMed ID: 26133738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
